The 2nd annual Market Access Day organized by EMAUD gathered over a hundred industry healthcare professionals. The event was an enriching meeting with a high level of interaction & discussion.
Multi-Indication Pricing: Pros, Cons and Applicability to the UK
2nd Annual Ma Day Feedback Note
1. 2nd Annual Market Access Day
Pricing of Pharmaceuticals:
Is There A Universal Foundation To Set A Fair Price?
3 December 2010 - Paris, Ecole du Val de Grâce
In the context of the current economic crisis and increasing budget constraints for healthcare
expenditure, pricing of pharmaceuticals has become an even more sensitive subject than usual. For
this reason, for the second annual Market Access Day in Paris, EMAUD gathered experts from North
America and Europe who contributed their viewpoints on the concept of fair pricing, answering the
question: “Pricing of pharmaceuticals: is there a universal foundation to set a fair price?”
Over a hundred healthcare industry professionals attended and the event was an enriching
meeting with a high level of interaction and discussion. Representatives from G-BA, NICE, EMA, EFPIA,
Andalusia, Catsalut, and INSERM, attended, as well as professors from the universities of Pittsburg,
McMaster, Twente, and Tufts. Speakers evaluated the performance of the pricing systems currently in
place and explored what could be the answer to setting a ‘fair price’ for pharmaceuticals. Many felt
that although all reforms aim at aligning value and price, affordability has become a key element of
market access. It is therefore difficult to draw specific lessons applicable to all markets and to supply a
single answer to define what fair pricing is; however, many countries are currently trying to integrate
objective affordability limits in their pricing practices. www.emaud.org